CIBC Global Asset Management »

Arbutus Biopharma shares owned by CIBC Global Asset Management

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by CIBC Global Asset Management from 13F filings

Historical chart of CIBC Global Asset Management investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by CIBC Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by CIBC Global Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $69k 14k 4.81

More positions owned by CIBC Global Asset Management

Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Cibc Cad (CM)
Barrick Mng Corp Com Shs (B)
Amazon (AMZN)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Bk Nova Cad (BNS)
Shopify Cl A Sub Vtg Shs (SHOP)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)

View all positions for CIBC Global Asset Management

Top funds holding Arbutus Biopharma

Whitefort Capital Management
BlackRock
Two Seas Capital
Vanguard Group
State Street Corporation
ADAR1 Capital Management
Adage Capital Partners GP
Geode Capital Management
Woodline Partners
BlackBarn Capital Partners
Rubric Capital Management
Charles Schwab Investment Management
Advisor Group Holdings
Northern Trust
Stempoint Capital

View all funds holding Arbutus Biopharma